Alnylam Pharmaceuticals

+$2.81 (+1.98%) As of 4:48 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.

About ALNY

Alnylam Pharmaceuticals, Inc. is a global commercial-stage biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. Its products include ONPATTRO, GIVLAARI, and OXLUMO.

CEO
Yvonne L. Greenstreet
Employees
1,665
Headquarters
Cambridge, Massachusetts
Founded
2002

ALNY Key Statistics

Market cap
17.52B
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.18M
High today
$145.19
Low today
$140.01
Open price
$142.23
Volume
179.84K
52 Week high
$212.00
52 Week low
$117.58

ALNY Earnings

-$1.84
-$1.23
-$0.61
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure